Dubai PR Network, Online Press Release from Dubai and Middle East
 
Healthcare(Healthcare & Medicine)
Filter PR by
  
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
 
NYU Abu Dhabi Researchers Design Proteins That Can Be Utilized to Combat Alzheimer's Disease
Protein-based therapeutics prevent protein aggregation associated with Alzheimer’s and other neurodegenerative diseases
 
Fast facts
● Alzheimer’s disease, an irreversible and progressive brain disorder, is the most common cause of dementia. 
● A hallmark of Alzheimer’s disease is the aggregation of the amyloid-β (Aβ) protein in a process that is toxic to the brain’s neurons. As neurons die, this slowly destroys memory and cognitive function. 
● NYUAD researchers have developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the Aβ protein. 
● The paper Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity has been published in Cell Reports Physical Science.
 
Abu Dhabi, UAE, February 7, 2020: A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the amyloid-β (Aβ) protein associated with Alzheimer’s disease. 
 
There is a growing interest in the use of proteins to develop treatments because they are biocompatible, biodegradable, and can selectively bind to specific targets, which reduces the potential for toxicity. Other pharmaceutically-desirable properties of proteins include greater chemical diversity than other biological molecule classes, and ease and low cost of production. However, a significant obstacle to the successful application of most proteins as therapeutics is their poor delivery to target organs and cells. 
 
In a new study, the Magzoub lab in collaboration with Professor and NYU President Andrew Hamilton’s lab at NYU New York and Professor Astrid Gräslund’s lab at Stockholm University, report that they have engineered CPPs that effectively prevent the aggregation of Aβ. CPPs are a special class of proteins that have the ability to reach all organs, including the brain, and to efficiently enter cells within these organs. Thus, the designed CPPs combine the attractive properties of proteins with potent therapeutic effects and highly efficient delivery to target cells.
 
A broad range of neurodegenerative diseases, including Huntington’s, Parkinson’s, and Alzheimer’s, are caused by the misfolding of disease-specific proteins. Once misfolded, these proteins build up in a process that damages neurons. Previously, the team showed that a naturally-derived CPP was able to protect against abnormal and harmful forms of the protein associated with prion diseases, a class of neurodegenerative disorders that include mad cow disease in cattle and Creutzfeldt-Jakob disease (CJD) in humans. Here, Magzoub and his collaborators extended this approach and specifically applied it to Alzheimer’s disease-causing Aβ malformation. 
 
In the paper titled Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity, the researchers present the process of designing the Aβ inhibitor CPPs. Using a range of techniques, they then extensively characterized the interactions of the designed CPPs with Aβ. Specifically, they used established aggregation and cell viability assays to determine the effects of the designed CPPs on the aggregation and associated neurotoxicity of Aβ. Simultaneously, they probed the cellular uptake and intracellular distribution of Aβ in the presence of the CPPs with confocal fluorescence microscopy. Finally, they used a combination of experiments and computer simulations to shed light on the mechanism of binding of the CPPs to Aβ. The results show that the designed CPPs stabilize the Aβ protein in a non-aggregated, non-abnormal state, and inhibit Aβ induced neurotoxicity.
 
The CPPs designed in this study effectively target Aβ outside and inside neurons, thereby protecting them against the damage caused by Aβ aggregation. “The designed CPPs represent a novel potential treatment strategy for Alzheimer’s disease,” said Magzoub. “These findings also reveal a general underlying principle for inhibition of pathogenic protein aggregation that will facilitate the design of even more potent CPP-based therapeutics for various neurodegenerative diseases.”


Posted by : DubaiPRNetwork.com Editorial Team
Viewed 12222 times
PR Category : Healthcare & Medicine
Posted on : Saturday, February 8, 2020  9:03:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Previous Story : Aster DM Healthcare Wins 6 Awards at AHPI Awards 2020
Next Story : Aster Hospitals Dubai achieves diamond level status from Acc...
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Section Home

Related Stories



 
 
Most Viewed Press Release posted in the last 7 days
Malabar Gold & Diamonds Celebrates Arab Mother's Day - Launches an Exclusive Jewellery Col... [26178-Views]
Marks & Spencer Ramadan Collection 2023 [8885-Views]
This Ramadan, Experience Precious Moments with Your Loved Ones at the St. Regis Dubai, the... [7626-Views]
EPA Features Unmissable Literary Offerings from Emirati Publishers at Oman and Saudi Arabi... [7339-Views]
A Clean Sweap for Skincare [6753-Views]
A Mother's Legacy, La Marquise Jewellery's Unique Pieces to Celebrate the most important W... [5871-Views]
Highlights of Day Two of Dubai Fashion Week AW 23/24 [5605-Views]
Union Coop: ‘Mock Evacuation' Drill Conducted at Etihad Mall in Cooperation with Dubai Civ... [5416-Views]
Embrace the “Ramadan Feeling” at GMG's Food Retail Stores this Holy Month [5330-Views]
OMEGA Partners with Mohammed Bin Rashid Space Centre [5186-Views]
Malabar Gold & Diamonds Adds More Sparkle to their Gold Rate Protection Offers; Block Gold... [5158-Views]
Forecasting Healthy Futures Hosts Inaugural Summit on Climate & Health [5154-Views]
Malabar Gold & Diamonds sets aside AED 1.7 Million for CSR activities during Ramadan 2023 [4686-Views]
Pogacar Completes Hat-Trick to take Paris-Nice Crown, Almeida Seals Big Weekend with Podiu... [4658-Views]
Celebrate Ramadan with Intellect Coffee's Cafe-on-wheels [4424-Views]
Bodour Al Qasimi Inaugurates AUS Global Day, a Carnival of Culture and Color [4272-Views]
Organizing Committee of NAS Sports Tournament Ratifies List of Teams Participating in the ... [4198-Views]
Become the Lucky Winner of AED2,000,000 Cash [4137-Views]
Festival in the Park: A Two-Day Celebration of Art, Music and Culture at Umm Al Emarat Par... [4116-Views]
Marina Rinaldi by Sara Battaglia [4043-Views]
Dubai Health Authority Announces Opening of Membership for its Electronic Medical Library [3915-Views]
National Bank of Fujairah to give Insights into the Outlook for the Marine Industry at a P... [3911-Views]
Monsha'at and Zoho to Accelerate SMEs' Digital Transformation and e-commerce Adoption [3710-Views]
UAE takes part in 58th Regular Session of the Council of Arab Ministers of Health [3694-Views]
Department of Municipalities and Transport Reports 6% Reduction in Service Fees for Real E... [3686-Views]
 
RSS Facebook Twitter LinkedDin DubaiPRNetwork.com on Instagram
 
Top Sections
 
Top Stories